Compare UK prices. 40+ products · 17 retailers scored
PeptideClear UK

Research peptides

Research peptides

OM

Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)

Last updated 2026-05-20

Research peptides are laboratory-grade peptide compounds sold in the UK under "research use only, not for human or animal consumption" framing. Sold without medicinal claims, they sit outside the MHRA medicines tier. The UK retailer pool includes my-peptides, Pure Peptides UK, Direct Sarms, Aquila, Pinnacle and Nooku. PeptideClear is editorial and informational only. Preclinical literature is summarised in encyclopedia format. We do not sell, we do not recommend dosing, and we do not endorse human use.

Inside this category

BPC-157

The most discussed research peptide. Animal data only, no human RCTs. Encyclopedia entry covering history, mechanism, and UK regulatory framing.

TB-500

Synthetic fragment of Thymosin beta-4. Preclinical wound healing and connective tissue literature. Research use only.

MOTS-c

Mitochondrial-derived peptide. Late-life intervention literature in mice. Nature Communications 2020.

Ipamorelin

Novo Nordisk-developed growth-hormone secretagogue. Phase II discontinued. Why pharmaceutical development stopped.

GHK-Cu

Copper-binding tripeptide with an extensive in-vitro and preclinical literature. Appears in both cosmetic and systemic research contexts.

Sermorelin

29-amino-acid GHRH analogue. Pharmaceutical history: Geref was approved then withdrawn in the US (2008). No UK marketing authorisation.

Tesamorelin

44-amino-acid stabilised GHRH analogue. FDA-approved in the US for HIV-associated lipodystrophy. No UK marketing authorisation.

Epitalon

Tetrapeptide bioregulator with a published preclinical literature from the St Petersburg Institute of Bioregulation. Research use only.

Melanotan

Melanocortin receptor agonists studied for UV-tanning activity in animal models. Significant safety-signal history. Research use only.

AOD-9604

HGH fragment. Phase III clinical programme discontinued. No marketing authorisation in any jurisdiction. Research use only.

PT-141 (Bremelanotide)

Melanocortin agonist. FDA-approved in the US as Vyleesi; no UK marketing authorisation. Research use only in the UK.

Selank

Synthetic Tuftsin analog registered in Russia. No UK or EU marketing authorisation. Russian clinical data reviewed honestly.

Semax

Synthetic ACTH (4-10) analog registered in Russia for stroke recovery. No UK or EU marketing authorisation. Research use only.

Kisspeptin-10

KISS1 gene product fragment studied at Imperial College London. Active academic research context. No UK licensed medicine.

UK retailer comparison

Side-by-side comparison of UK research peptide retailers: my-peptides, Pure Peptides UK, Direct Sarms, Aquila, Pinnacle, Nooku. Purity claims, CoA standards, delivery.

UK regulatory framing (briefly)

  • · The Medicines Act 1968 + Human Medicines Regulations 2012 govern any product marketed as a medicine in the UK.
  • · Research peptides marketed as "research use only" with no health claims sit outside that tier.
  • · Once a retailer or commentator makes a health claim ("heals tendons", "improves recovery", "use at X mg"), the product is treated as an unlicensed medicinal product. MHRA enforcement follows.
  • · £45m of trafficked weight-loss medicines and "peptide products" were seized by MHRA in early 2026 (Northampton Oct 2025, Sleaford 2026). Sites making medicinal claims are the enforcement priority.

Our editorial framing on every research peptide page is encyclopedia. History, mechanism, animal literature, regulatory status. No dosing, no human-use protocols, no cycle stacks. Where we link out to retailers, the retailer's "research use only" framing applies to the transaction.

Popular on PeptideClear

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-05-20